Literature DB >> 19734934

A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery.

Yoshihisa Namiki1, Tamami Namiki, Hiroshi Yoshida, Yukiko Ishii, Akihito Tsubota, Shigeo Koido, Kouichi Nariai, Makoto Mitsunaga, Satoru Yanagisawa, Hideyuki Kashiwagi, Yasuo Mabashi, Yoko Yumoto, Sadayori Hoshina, Kiyotaka Fujise, Norio Tada.   

Abstract

Cancer gene therapy requires a safe and effective gene delivery system. Polymer- and lipid-coated magnetic nanocrystals have been used to deliver silencing RNA, but synthesizing these magnetic vectors is difficult. Here, we show that a new nanoparticle formulation can be magnetically guided to deliver and silence genes in cells and tumours in mice. This formulation, termed LipoMag, consists of an oleic acid-coated magnetic nanocrystal core and a cationic lipid shell. When compared with the commercially available PolyMag formulation, LipoMag displayed more efficient gene silencing in 9 of 13 cell lines, and better anti-tumour effects when systemically administered to mice bearing gastric tumours. By delivering an optimized sequence of a silencing RNA that targets the epidermal growth factor receptor of tumour vessels, the intended therapeutic benefit was achieved with no evident adverse immune reaction or untoward side effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734934     DOI: 10.1038/nnano.2009.202

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


  27 in total

1.  Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.

Authors:  K Berg; P K Selbo; L Prasmickaite; T E Tjelle; K Sandvig; J Moan; G Gaudernack; O Fodstad; S Kjølsrud; H Anholt; G H Rodal; S K Rodal; A Høgset
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

2.  Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.

Authors:  Yoshihisa Namiki; Tamami Namiki; Hiroshi Yoshida; Masataka Date; Masakazu Yashiro; Kunio Matsumoto; Toshikazu Nakamura; Kazuyoshi Yanagihara; Norio Tada; Jujin Satoi; Kiyotaka Fujise
Journal:  Int J Cancer       Date:  2006-03-15       Impact factor: 7.396

3.  Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.

Authors:  Adam D Judge; Gurneet Bola; Amy C H Lee; Ian MacLachlan
Journal:  Mol Ther       Date:  2005-12-15       Impact factor: 11.454

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa.

Authors:  Y Namiki; T Takahashi; T Ohno
Journal:  Gene Ther       Date:  1998-02       Impact factor: 5.250

6.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

7.  Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo.

Authors:  Florian Krötz; Cor de Wit; Hae Young Sohn; Stefan Zahler; Torsten Gloe; Ulrich Pohl; Christian Plank
Journal:  Mol Ther       Date:  2003-05       Impact factor: 11.454

8.  Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome.

Authors:  Yoshihisa Namiki; Tamami Namiki; Masataka Date; Kazuyoshi Yanagihara; Masakazu Yashiro; Hiroshi Takahashi
Journal:  Pharmacol Res       Date:  2004-07       Impact factor: 7.658

9.  Delivery of small interfering RNA for inhibition of endothelial cell apoptosis by hypoxia and serum deprivation.

Authors:  Seung-Woo Cho; Lauren Hartle; Sun Mi Son; Fan Yang; Michael Goldberg; Qiaobing Xu; Robert Langer; Daniel G Anderson
Journal:  Biochem Biophys Res Commun       Date:  2008-08-31       Impact factor: 3.575

10.  Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors.

Authors:  Shawkat-Muhialdin Jangi; M Begoña Ruiz-Larrea; Francesca Nicolau-Galmés; Noelia Andollo; Yoana Arroyo-Berdugo; Idoia Ortega-Martínez; José Luís Díaz-Pérez; María D Boyano
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

View more
  64 in total

1.  Inorganic-organic magnetic nanocomposites for use in preventive medicine: a rapid and reliable elimination system for cesium.

Authors:  Yoshihisa Namiki; Tamami Namiki; Yukiko Ishii; Shigeo Koido; Yuki Nagase; Akihito Tsubota; Norio Tada; Yoshitaka Kitamoto
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

Review 2.  Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.

Authors:  Ki Young Choi; Gang Liu; Seulki Lee; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2011-12-01       Impact factor: 7.790

3.  Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

Authors:  Forrest M Kievit; Omid Veiseh; Chen Fang; Narayan Bhattarai; Donghoon Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  ACS Nano       Date:  2010-08-24       Impact factor: 15.881

4.  Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.

Authors:  Hua Pan; Jacob W Myerson; Olena Ivashyna; Neelesh R Soman; Jon N Marsh; Joshua L Hood; Gregory M Lanza; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2010-03-24       Impact factor: 5.191

Review 5.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

Review 6.  Polymeric materials for theranostic applications.

Authors:  Zhe Wang; Gang Niu; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-06-14       Impact factor: 4.200

7.  Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.

Authors:  Sanjay Singh
Journal:  Bioimpacts       Date:  2013-01-14

Review 8.  Functional magnetic nanoparticles for non-viral gene delivery and MR imaging.

Authors:  Ruijun Xing; Gang Liu; Jinghan Zhu; Yanglong Hou; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

9.  Nanomedicine: Silence the target.

Authors:  Christian Plank
Journal:  Nat Nanotechnol       Date:  2009-08-23       Impact factor: 39.213

Review 10.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.